Allergies are on the rise: Dr. Marc Siegel
Pollen bomb coming
Asian stocks mostly up after Wall Street finishes higher
U.S. stocks are climbing Thursday morning as technology companies, banks and industrial companies rally.
Boehner, Weld-backed pot company IPO bound
The former Massachusetts governor says the company that he and former Speaker John Boehner are advising wants to become a dominant cannabis player.
Made in China 2025 plan irking Beijing's trading partners
U.S. officials have a name for their frustration with Beijing's technology ambitions: "Made in China 2025."
Takata acquired by Key Safety Systems, president resigns
Takata Corp., the Japanese air bag maker embroiled in a massive recall, says the acquisition by U.S. mobility safety company Key Safety Systems has been completed, and the president resigned.
Insurers look to pass drug price breaks straight to consumer
Some major health insurers plan to take a little sting out of prescription drug prices by giving customers rebates at the pharmacy counter.
Asian stocks mostly rise as investors weigh trade war fears
U.S. stocks are edging higher Monday after concerns about growing trade tensions between the U.S. and China sent stocks lower last week.
California bill would create health care price controls
California's government would set prices for hospital stays, doctor visits and other health care services under legislation introduced Monday, vastly remaking the industry in a bid to lower health care costs.
Markets Right Now: Early rally mostly fades on Wall Street
The latest on developments in financial markets (all times local): 9:35 a.m.
Uber, Lyft stand to gain from Medicare Advantage benefit expansion
Medicare Advantage patients could soon get discounted rides to the doctor or pharmacy as the Trump administration expands benefits under the program.
Legendary soul man Sam Moore backs new implant to treat opioid addiction
Naltrexone is implanted beneath the skin to manage opioid dependence
Swiss giant Novartis to buy US-based AveXis in $8.7B deal
Swiss pharmaceuticals giant Novartis says it has agreed to buy the U.S.-based gene therapy company AveXis Inc. for $8.7 billion, part of its goal to become a leader in the treatment of neurodegenerative diseases.
Novartis to buy AveXis for $8.7 billion
Novartis is buying U.S. gene therapy company AveXis for $8.7 billion
Ohio company recalls more than 7 tons of BBQ beef
Federal authorities say an Ohio-based food company is recalling more than 14,000 pounds (6,000 kilograms) of pulled barbequed beef products that could be contaminated with rubber.
Gov't says Zipcar may have rented unrepaired recalled van
The U.S. government's road safety agency says it will audit Zipcar after getting information that the company rented at least one recalled vehicle without making repairs.
Ford recalls trucks, SUVs for transmission shifter problem
Ford is recalling about 350,000 trucks and SUVs in the U.S., Canada and Mexico because they might be in a different gear than the one shown on the shift indicator.
J&J loses trial over claims linking cancer to asbestos in talc
Johnson & Johnson suffered its first trial loss in a lawsuit over its talc-based products.
Growing concerns among parents, teachers over the Juuling epidemic
Combating the Juuling epidemic
U.S. Obamacare 2018 exchange enrollment drops 3 percent: CMS
The number of people enrolled in Obamacare declined by 3% from last year.
Trump targets drug prices for Medicare beneficiaries
The Trump administration is encouraging competition by promoting expanded consumer options.















